Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

GLAXOSMITHKLINE PLC

SynthèseActualitésNotationsAgendaSociétéFondsCommunauté 
Métier
GlaxoSmithKline plc est le 2e groupe pharmaceutique mondial. Le CA par famille de produits se répartit comme suit :

- produits pharmaceutiques (50%) : destinés au traitement des maladies respiratoires (64,9% du CA), de l'infection par le VIH (28,6%), des troubles du système immunitaire (4,3%) et des cancers (2,2%) ;

- médicaments OTC et parapharmaceutiques (29,4%) ;

- vaccins (20,5%) ;

- autres (0,1%).

La répartition géographique du CA est la suivante : Royaume Uni (2,9%), Etats-Unis (42,7%) et autres (54,4%).
Dirigeants
Nom AgeDepuisTitre
Emma Walmsley512017Chief Executive Officer & Executive Director
Iain Mackay592019Chief Financial Officer & Executive Director
Karenann Terrell582017Chief Digital & Technology Officer
Hal Barron572018Executive Director & Chief Scientific Officer
Jon Ellis532019VP & Head-Technology Business Development
Amy Altshul--SVP-Legal, Research & Development
Nick Hirons-2014Senior Vice President-Global Ethics & Compliance
Lynn Laverty Elsenhans632012Independent Non-Executive Director
Urs Rohner612015Independent Non-Executive Director
Manvinder Singh Banga652016Senior Independent Non-Executive Director
Administrateurs
Nom AgeDepuisTitre
Jonathan Symonds612019Non-Executive Chairman
Emma Walmsley512017Chief Executive Officer & Executive Director
Lynn Laverty Elsenhans632012Independent Non-Executive Director
Urs Rohner612015Independent Non-Executive Director
Manvinder Singh Banga652016Senior Independent Non-Executive Director
Jesse Goodman, Dr.682016Independent Non-Executive Director
Vivienne Cox602016Independent Non-Executive Director
Laurie H. Glimcher, Dr.682017Independent Non-Executive Director
Hal Barron572018Executive Director & Chief Scientific Officer
Iain Mackay592019Chief Financial Officer & Executive Director
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 5 386 650 226 4 972 405 586 92.3% 355 205 950 6.6% 92.3%
Actionnaires
Nom Actions%
The Vanguard Group, Inc. 136 970 000 2,72%
BlackRock Fund Advisors 131 211 690 2,61%
BlackRock Investment Management (UK) Ltd. 128 982 522 2,56%
Norges Bank Investment Management 123 870 000 2,46%
Dodge & Cox 99 377 874 1,98%
Capital Research & Management Co. (Global Investors) 97 314 557 1,93%
State Street Global Advisors Ltd. 66 788 845 1,33%
Schroder Investment Management Ltd. 66 166 875 1,32%
BlackRock Advisors (UK) Ltd. 65 102 968 1,29%
Capital Research & Management Co. (World Investors) 55 509 306 1,10%
Participations
Nom Actions%Valorisation
Vir Biotechnology, Inc. (VIR) 6 626 0275,18%339 716 404 USD
GlaxoSmithKline Pakistan Limited (GLAXO) 263 029 79482,6%270 573 488 USD
Theravance Biopharma, Inc. (TBPH) 9 644 80714,8%196 850 511 USD
GlaxoSmithKline S.A.E (BIOC) 76 161 37891,2%147 258 786 USD
GlaxoSmithKline Consumer Healthcare Pakistan Limited (GSKCH) 100 423 25985,8%141 980 412 USD
Nkarta, Inc. (NKTX) 3 082 3429,40%101 409 052 USD
Bicycle Therapeutics Limited 1 616 2957,59%48 278 732 USD
Dong-A Socio Holdings Co., Ltd. (A000640) 409 6936,66%39 095 954 USD
Fulcrum Therapeutics, Inc. (FULC) 1 785 7145,47%21 035 711 USD
Allergy Therapeutics plc (AGY) 10 118 0001,58%2 861 775 USD
Coordonnées société
GlaxoSmithKline Plc
980 Great West Road
Brentford
Middlesex, Greater London TW8 9GS

Phone : +44.20.8047.5000
Fax : +44.20.8047.7807
Web : http://gsk.com
Secteur Pharmacies - Autres
Var. 1janvCapitalisation (M$)
GLAXOSMITHKLINE PLC96 628
JOHNSON & JOHNSON8.16%447 572
ROCHE HOLDING AG-2.57%286 766
PFIZER, INC.8.94%223 684
ABBVIE INC.8.66%205 942
MERCK & CO., INC.-4.29%199 248
NOVARTIS AG-4.30%198 079
NOVO NORDISK A/S12.23%178 669
ELI LILLY AND COMPANY16.21%177 205
BRISTOL-MYERS SQUIBB COMPANY4.85%145 224
AMGEN INC.9.63%144 828
ASTRAZENECA PLC7.37%144 632
SANOFI10.19%130 765
GLAXOSMITHKLINE PLC2.12%95 023
BAYER AG18.49%67 701
JIANGSU HENGRUI MEDICINE CO., LTD.-24.79%67 255
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-25.13%58 604
TAKEDA PHARMACEUTICAL COMPANY LIMITED-0.40%52 491
DAIICHI SANKYO COMPANY, LIMITED-23.55%47 097
CHANGCHUN HIGH & NEW TECHNOLOGY INDUSTRY (GROUP) INC.15.15%31 177